Pal-GQPR (Palmitoyl Tetrapeptide-7)
You may regain 12 pounds in water weight as appetite returns, but your metabolic changes and fat loss remain intact
Guo W., Tian W., Lin L., Xu X
In general, patients with the following characteristics may be good candidates for Tirzepatide: A Body Mass Index (BMI) of 30 or higher A Body Mass Index (BMI) of 27 or higher when at least one comorbidity is present, such as insulin resistance, hypertension, high cholesterol, sleep apnea, or gout
Peak effects are typically reached between weeks 40 and 48, with the 12mg dose group achieving an average of 24.2% total body weight loss